Insider · CIK 0002030813
Thomas Trimarchi
coopresidentofficercfo
Files at BBIO (BridgeBio Pharma, Inc.). First filing Aug 19, 2025, latest Nov 18, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $4.1M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BBIO: BridgeBio Pharma, Inc.
BBIOOct 9, 2026 · close 65.35
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | BridgeBio Pharma, Inc. | $1.1M 16,934 shares | -4% | +199% from low0% from high | |
| 62Notable | BridgeBio Pharma, Inc. | $2.1M 42,237 shares | -9% | +125% from low-2% from high | |
| 40Moderate | BridgeBio Pharma, Inc. | $872k 17,353 shares | -4% | +119% from low-4% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock | -13,826 | $75.15 | $1.0M | 369,004 | Dec 16, 2025 |
| Nov 16, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock10b5-1 | -21,317 | $66.39 | $1.4M | 399,764 | Nov 18, 2025 |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -9,978 | $66.19 | $660k | 389,786 | Nov 18, 2025 |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -6,956 | $66.84 | $465k | 382,830 | Nov 18, 2025 |
| Aug 21, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock | -42,237 | $49.48 | $2.1M | 421,081 | Aug 22, 2025 |
| Aug 16, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock10b5-1 | -21,317 | $51.32 | $1.1M | 480,671 | Aug 19, 2025 |
| Aug 18, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -15,380 | $50.14 | $771k | 465,291 | Aug 19, 2025 |
| Aug 18, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -1,973 | $50.94 | $101k | 463,318 | Aug 19, 2025 |
| May 16, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock | -21,317 | $33.84 | $721k | 501,988 | May 20, 2025 |
| Mar 19, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Common Stock | +109,100 | $0.00 | $0 | 523,305 | Mar 21, 2025 |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock | -13,782 | $34.90 | $481k | 414,205 | Feb 19, 2025 |
| Dec 10, 2024 | BBIO BridgeBio Pharma, Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 427,987 | Dec 12, 2024 |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock | -17,936 | $23.72 | $425k | 377,987 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.